Synflorix licence extended for use in children up to 5 years old

The deltoid muscle of the upper arm in young children and the anterolateral thigh in infants are the preferred sites of injection | SCIENCE PHOTO LIBRARY
The deltoid muscle of the upper arm in young children and the anterolateral thigh in infants are the preferred sites of injection | SCIENCE PHOTO LIBRARY

Synflorix (pneumococcal vaccine) can now be prescribed for use in children from 2–5 years of age.

The recommended vaccination schedule consists of 2 doses of 0.5ml with a minimum interval of 2 months between doses. It is recommended that children who receive a first dose of Synflorix should complete the full vaccination course with Synflorix. A 6-month booster dose should be given according to the dose regimen that is appropriate to their age at the time of commencing the vaccination series.

This licence extension now means that the vaccine can be given to children from 6 weeks up to 5 years of age.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more